EFFECTS OF THERAPEUTIC DOSES OF HEPARIN ON MSC FUNCTIONAL ACTIVITY IN MODELING THE MECHANISMS OF OSTEOINTEGRATION UNDER IN VITRO CULTIVATION
I.К. Norkin¹, К.А. Yurova¹, О.G. Khaziahmatova¹, V.V. Malashchenko¹, D.D. Ligatyuk¹, I.А. Khlusov², L.S. Litvinova¹
DOI: 10.22138/2500-0918-2022-19-3-231-240
¹ Center of Immunology and Cellular Biotechnology, I. Kant Baltic Federal University,
Kaliningrad, Russian Federation;
² Siberian State Medical University (SSMU), Tomsk, Russian Federation
Abstract. The use of artificial materials in regenerative medicine is accompanied by the development of an inflammatory response and the initiation of blood clotting due to the contact of the implant with the soft tissues of the body. All this leads to the formation of thrombosis of the major and main arteries and the development of serious complications. To prevent the development of postoperative pathological conditions caused by hypercoagulable syndrome, classical therapeutic strategies with anticoagulants (mainly heparin) are used. However, the described treatment tactics lead to an interruption of the migration and adhesion processes of mesenchymal stem cells (MSC), which negatively affects the callus formation and the processes of osseointegration of the implant. The aim of this study was to investigate the effect of a suspension of HA nanoparticles in the presence of heparin in a gradient of therapeutic concentrations on migratory and proliferative activity of MSCs in human adipose tissue under in vitro cultivation conditions. Methods. To evaluate the migration and proliferation potential of MSC in the presence of HA nanosuspension and/or heparin, an electrode system for continuous observation — xCELLigence ® RTCA DP was used. Results. A significant decrease in the migratory activity and proliferative potential of MSC was observed under the conditions of their co-cultivation with HA nanosuspension in the presence/absence of heparin (0.5–1 IU/ml). onclusion. The results of the study may serve as a prerequisite for the development of new therapeutic approaches for the use of heparin in surgical patients at high risk of postoperative thrombosis after osteosynthesis.
Keywords: mesenchymal stem cells, heparin, implant, RTCA, migration, in vitro
There is no conflict of interest.
Contact details of the corresponding author:
Igor K. Norkin
norkin_igor@mail.ru
Received 26.07.2022
For citation:
Norkin I.K., Yurova K.A., Khaziahmatova O.G., Malashchenko V.V., Ligatyuk D.D., Khlusov I.A., Litvinova L.S. Effects of therapeutic doses of heparin on MSC functional activity in modeling the mechanisms of osteointegration under in vitro cultivation. Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2022, Vol. 19, no. 3, pp. 231–240. DOI: 10.22138/2500-0918-2022-19-3-231-240 (In Russ)
REFERENCES
1. Chen Q., Sivakumar P., Barley C., Peters D.M., Gomes R.R., Farach-Carson M.C. et al. Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J Biol Chem. 2007;2 82: 26418–30.
2. Cuker A., Arepally G.M., Chong B.H., Cines D.B., Greinacher A., Gruel Y. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018; 2: 3360–92.
3. Edeer A.D., Comez S., Damar H.T., savci A. Prevalence and risk factors of venous thromboembolism in postoperative patients: A retrospective study. Pak J Med Sci. 2018; 34: 1539–44.
4. Fu D., Jiang Q., He F., Fu B. et al. Adhesion of bone marrow mesenchymal stem cells on porous titanium surfaces with strontium-doped hydroxyapatite coating. J Zhejiang Univ Sci B. 2017; 18: 778–88.
5. Gorbet M.B., Sefton M.V. et al. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004; 2 5: 5681–703.
6. Hu J., Zhou Y., Huang L., Liu J., Lu H. et al. Effect of nano-hydroxyapatite coating on the osteoinductivity of porous biphasic calcium phosphate ceramics. BMC Musculoskelet Disord. 2014; 15: 114.
7. Labarrere C.A., Dabiri A.E., Kassab G.S. et al. Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices. Front Bioeng Biotechnol. 2020; 8.
8. Laner-Plamberger S., Lener T., Schmid D., Streif D.A., Salzer T., Öller M. et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015; 13: 354.
9. Norkin I.K., Yurova K.A., Khaziahmatova O.G., Melashchenko E.S., Malashchenko V.V., Shun’kin E.O. i dr. Stimuliruyushchee vliyanie vysokih doz geparina na migracionnuyu aktivnost’ i sohranenie stvolovosti MSK v prisutstvii osteozameshchayushchih materialov. Medicinskaya Immunologiya. 2021; 23: 831–8 (in Russ).
10. Seeger F.H., Rasper T., Fischer A., Muhly-Reinholz M., Hergenreider E., Leistner D.M. et al. Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circ Res. 2012; 111: 854–62.
11. Shahpazyan N.K., Astrelina T.A., Yakovleva M.V. i dr. Mezenhimal’nye stvolovye kletki iz razlichnyh tkanej cheloveka: biologicheskie svojstva, ocenka kachestva i bezopasnosti dlya klinicheskogo primeneniya. Kletochnaya Transplantologiya I Tkanevaya Inzheneriya. 2012; 7.(in Russ)
Authors
Igor K. Norkin
Center of Immunology and Cellular Biotechnologies, IKBFU
PhD student, technician
6 st. Gaidar Kaliningra Russian Federation 236001
norkin_igor@mail.ru
Kristina A. Yurova
Center of Immunology and Cellular Biotechnologies, IKBFU
PhD of Medical Sciences, Senior Researcher
6 st. Gaidar Kaliningra Russian Federation 236001
kristina_kofanova@mail.ru
Olga G. Khaziakhmatova
Center of Immunology and Cellular Biotechnologies, IKBFU
PhD of Biological Sciences, Senior Researcher
6 st. Gaidar Kaliningra Russian Federation 236001
hazik36@mail.ru
Vladimir V. Malashchenko
Center of Immunology and Cellular Biotechnologies, IKBFU
PhD of Biological Sciences, Researcher
6 st. Gaidar Kaliningra Russian Federation 236001
vmalashchenko@kantiana.ru
Denis D. Ligatyuk
Center of Immunology and Cellular Biotechnologies, IKBFU
Laboratory engineer
6 st. Gaidar Kaliningra Russian Federation 236001
Igor A. Khlusov
M.D., Professor of the Department of Morphology and General Pathology
Siberian State Medical University (SSMU)
2 Moskovsky Trakt Tomsk Russian Federation 634050
khlusov63@mail.ru
Larisa S. Litvinova
Center of Immunology and Cellular Biotechnologies, IKBFU
M.D., Director of the Center of Immunology and Cellular Biotechnologies, IKBFU
6 st. Gaidar Kaliningra Russian Federation 236001
larisalitvinova@yandex.ru